In a piece of good news, Mumbai’s Worli Koliwada and adjoining Jijamata Nagar have not reported a single case of coronavirus in the last 10 days.
According to reports, the areas now have only one active case each. The areas that fall under the G-South ward were once listed among areas with most cases and Worli Koliwada was marked as Mumbai’s first containment zone in April 2020.
Moreover, the officials informed that there has been no new case in Worli Koliwada and Jijamata Nagar since June 7. So far, the areas have reported 1,099 cases and the densely populated enclaves have seen 70 deaths; 1,027 patients have recovered.
In 2020, when the COVID-19 cases increased in Mumbai, officials from the civic body, Brihanmumbai Municipal Corporation (BMC) feared the spread in Worli Koliwada, and to implement a strict protocol, citizens from the area were instructed not to leave the locality for over two months, which eventually helped the administration, manage the crisis effectively.
Meanwhile, the ongoing second wave of coronavirus spread is not easy to manage, as several parts of the country, are facing the brunt, with poor infrastructure and healthcare facilities.
On the other hand, amidst concerns over the high cost of Covishield and Covaxin shots in private hospitals, the vaccine manufacturers -- Serum Institute of India (SII) and Bharat Biotech (BB) -- are seeking higher prices for COVID-19 vaccines from the Centre.
Both companies recently sought a price increase, arguing that the current government-procurement price is “unsustainable”, especially in line with the substantial investments that have gone towards producing vaccines.
ALSO READ: BMC orders investigation after alleged fraud in COVD-19 vaccine camp in Mumbai's society
Share
Tweet
